Axsome Therapeutics Inc

Senior Manager, Global Clinical Regulatory Leader (Remote)

United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalIndustries

About PTC Therapeutics

PTC Therapeutics is a global commercial biopharmaceutical company. For over 25 years our team has been deeply committed to a unified purpose: Extending life’s moments for children and adults living with a rare disease.

At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.

Visit our website to learn more about our company and culture! Site: www.ptcbio.com

Job Description Summary

The Senior Manager, Global Clinical Regulatory Lead, is responsible for providing strategic and operational direction for the planning, management, support and execution of regulatory activities for PTC drug products (clinical and commercial) within the US as applicable. This role includes responsibility for support of global clinical trials, regional registrations and life cycle management regulatory activities. This individual supports the Global Regulatory Lead on their assigned products.

This position collaborates with others in the Regulatory Affairs Strategy team, Regulatory Sub teams, and potential cross-functional teams on assigned projects.

The role is responsible for overseeing the IND submission in the US, as well as for clinical trials applications for the rest of world. Additionally, this role supports the GRL to ensure that regional regulatory strategies are executed in compliance with current, applicable regulations and standards.

This position works cross-functionally and serves as a liaison between Global Regulatory Affairs team members, other PTC departments, external service providers and contract manufacturers.

The Senior Manager, Regulatory Affairs US ensures adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs) as appropriate.

Responsibilities

  • Collaborates and attends meetings with project teams and other internal and external key stakeholders as appropriate to ensure effective local product registrations.
  • Ensures that drug and biologic products distributed within the region meet local regulatory requirements while also supporting PTC’s commercial/business objectives.
  • Provides regulatory support to the Global Pharmacovigilance (PV) organization and regional/country representatives as necessary to ensure that PTC’s PV obligations within the region are met.
  • Performs other tasks and assignments as needed and specified by management.

Global Regulatory Strategy Support

  • Works closely with GRL in the preparation of Global Regulatory Strategy for assigned projects.
  • Maintain current knowledge of relevant regulations, including proposed and final rules as well as updated regulatory guidance.
  • Prepare global regulatory strategy for drugs and gene therapies through conducting research, preparation of labeling documents, and additional regulatory submissions.
  • Analyze clinical, non-clinical and CMC development work in context with global regulatory guidance to develop global regulatory strategies.
  • Prepare CCDS (company core data sheet), US-PI and SmPC.
  • Prepare and review regulatory submissions for domestic or international projects, such as Rare Pediatric Disease Designation (RPDD) applications, Orphan Drug Designation (ODD) applications, Annual Reports, and Development Safety Update Reports (DSURs), Scientific Advice briefing books, pre-IND, IND, Briefing Books, and MAA/BLA/NDAs.
  • Performs other tasks and assignments as needed and specified by management.

Clinical Trial Applications (CTAs)

  • Initiate and execute CTA/CTNs in US, EU, and globally by keeping up to date with regulations and critically analyzing the interactions with health authorities to ensure that any outstanding issues are addressed.
  • Liaise and attend essential meetings between Contract Research Organizations (CROs) and PTC regulatory team to retrieve documents as needed for submissions to Health Authorities internationally.
  • Align with CROs, IRL and GRLs on timelines for development and submission of CTAs.

Skills

Regulatory Affairs
Clinical Trials
IND Submission
Global Regulatory Strategy
Life Cycle Management
Biopharmaceutical
Regulatory Compliance
SOPs

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI